实用医学杂志
實用醫學雜誌
실용의학잡지
THE JOURNAL OF PRACTICAL MEDICINE
2014年
15期
2387-2390
,共4页
杨景哲%陈凤平%冯欣姝%温海玲%耿琪瑛
楊景哲%陳鳳平%馮訢姝%溫海玲%耿琪瑛
양경철%진봉평%풍흔주%온해령%경기영
烧伤%重组人粒细胞巨噬细胞集落刺激因子%纳米银%VEGF%EGF
燒傷%重組人粒細胞巨噬細胞集落刺激因子%納米銀%VEGF%EGF
소상%중조인립세포거서세포집락자격인자%납미은%VEGF%EGF
Burns%Recombinant human granulocyte-macrophage colony stimulating factor%Nano-silver%VEGF%EGF
目的:研究重组人粒细胞巨噬细胞集落刺激因子(rhGM-CSF)联合纳米银对深Ⅱ°烫伤治疗作用的影响。方法:Wistar大鼠建立深Ⅱ°烫伤模型,分为4组,A组(30只):凡士林纱布覆盖,B组(30只):纳米银覆盖,C 组(30只):rhGM-CSF涂抹,D 组(30只):rhGM-CSF+纳米银覆盖,伤后第1、4、7、10、14、21天,观察创面愈合,计算愈合率,酶联免疫吸附法测定血清中血管内皮生长因子(VEGF)和表皮生长因子(EGF)水平。结果:第10天各组开始愈合,愈合过程A组炎症反应明显,B、C组适中,D 组适度;创面愈合率,第10、14、21天组间差异有统计学意义(P<0.05);VEGF 水平,A 组第21天达峰值为(25.76±1.46)pg/mL,B、C、D 组第14天达峰值[(29.73±1.58),(38.91±2.38),(43.54±1.28)pg/mL],第4、7、10、14、21天组间差异有统计学意义(P<0.05);EGF水平,各组均在第21天达峰值[(0.72±0.14),(0.93±0.13),(1.18±0.16),(1.50±0.15)ng/mL],第7、10、14、21天组间差异有统计学意义(P<0.05)。结论:rhGM-CSF 联合纳米银,促进深Ⅱ°烫伤创面愈合,并且优于rhGM-CSF、纳米银单独应用。
目的:研究重組人粒細胞巨噬細胞集落刺激因子(rhGM-CSF)聯閤納米銀對深Ⅱ°燙傷治療作用的影響。方法:Wistar大鼠建立深Ⅱ°燙傷模型,分為4組,A組(30隻):凡士林紗佈覆蓋,B組(30隻):納米銀覆蓋,C 組(30隻):rhGM-CSF塗抹,D 組(30隻):rhGM-CSF+納米銀覆蓋,傷後第1、4、7、10、14、21天,觀察創麵愈閤,計算愈閤率,酶聯免疫吸附法測定血清中血管內皮生長因子(VEGF)和錶皮生長因子(EGF)水平。結果:第10天各組開始愈閤,愈閤過程A組炎癥反應明顯,B、C組適中,D 組適度;創麵愈閤率,第10、14、21天組間差異有統計學意義(P<0.05);VEGF 水平,A 組第21天達峰值為(25.76±1.46)pg/mL,B、C、D 組第14天達峰值[(29.73±1.58),(38.91±2.38),(43.54±1.28)pg/mL],第4、7、10、14、21天組間差異有統計學意義(P<0.05);EGF水平,各組均在第21天達峰值[(0.72±0.14),(0.93±0.13),(1.18±0.16),(1.50±0.15)ng/mL],第7、10、14、21天組間差異有統計學意義(P<0.05)。結論:rhGM-CSF 聯閤納米銀,促進深Ⅱ°燙傷創麵愈閤,併且優于rhGM-CSF、納米銀單獨應用。
목적:연구중조인립세포거서세포집락자격인자(rhGM-CSF)연합납미은대심Ⅱ°탕상치료작용적영향。방법:Wistar대서건립심Ⅱ°탕상모형,분위4조,A조(30지):범사림사포복개,B조(30지):납미은복개,C 조(30지):rhGM-CSF도말,D 조(30지):rhGM-CSF+납미은복개,상후제1、4、7、10、14、21천,관찰창면유합,계산유합솔,매련면역흡부법측정혈청중혈관내피생장인자(VEGF)화표피생장인자(EGF)수평。결과:제10천각조개시유합,유합과정A조염증반응명현,B、C조괄중,D 조괄도;창면유합솔,제10、14、21천조간차이유통계학의의(P<0.05);VEGF 수평,A 조제21천체봉치위(25.76±1.46)pg/mL,B、C、D 조제14천체봉치[(29.73±1.58),(38.91±2.38),(43.54±1.28)pg/mL],제4、7、10、14、21천조간차이유통계학의의(P<0.05);EGF수평,각조균재제21천체봉치[(0.72±0.14),(0.93±0.13),(1.18±0.16),(1.50±0.15)ng/mL],제7、10、14、21천조간차이유통계학의의(P<0.05)。결론:rhGM-CSF 연합납미은,촉진심Ⅱ°탕상창면유합,병차우우rhGM-CSF、납미은단독응용。
Objective To observe the effect of recombinant human granulocyte/macrophage colonystimulating factor (rhGM-CSF) combined with nano-silver for deep burn degreen Ⅱ. Methods The burn model were done with Wistar rats. They were randomly divided into four groups , group A (n = 30): petrolatum treatment, group B(n = 30): nano-silver treatment, group C(n = 30): rhGM-CSF treatment, and group D(n =30): rhGM-CSF combined with nano-silver treatment. The healing rates of the four groups were observed on postburn day 1, 4, 7, 10, 14, 21. Meanwhile the levels of VEGF and EGF in serums were measured with ELISA. Results All groups started to heal on postburn day 10. Group A had inflammation obviously , and group D moderately. There were significant difference in the healing retes on postburn day 10 , 14, 21 between four groups (P < 0.05). The level of VEGF in group A peaked on postburn day 21 (25.76 ± 1.46)pg/mL, but the levels of VEGF in group B, group C and group D peaked on postburn day 14[(29.73 ± 1.58)pg/mL, (38.91 ± 2.38)pg/mL, (43.54 ± 1.28)pg/mL]. On postburn day 4, 7, 10, 14, 21, there were significant difference(P <0.05). The level of EGF peaked on postburn day 21 in all groups [(0.72 ± 0.14)ng/mL, (0.93 ± 0.13)ng/mL, (1.18 ± 0.16)ng/mL, (1.50 ± 0.15)ng/mL]. There were significant difference on postburn day 7, 10, 14, 21 between four groups (P < 0.05). Conclusions rhGM-CSF combined with nano-silver treatment could promote wound healing, and be better than rhGM-CSF and nano-silver singly.